

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interferon-alpha (GO:0035457) | 7.58254410 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.62311514 |
| 3 | positive regulation of natural killer cell differentiation (GO:0032825) | 6.57927052 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.19614129 |
| 5 | regulation of RIG-I signaling pathway (GO:0039535) | 6.06232515 |
| 6 | positive regulation of type 2 immune response (GO:0002830) | 5.65855879 |
| 7 | glycosphingolipid catabolic process (GO:0046479) | 5.64041011 |
| 8 | regulation of mononuclear cell migration (GO:0071675) | 5.45182501 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 5.34962204 |
| 10 | oligosaccharide catabolic process (GO:0009313) | 5.27540237 |
| 11 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.26926136 |
| 12 | cellular response to type I interferon (GO:0071357) | 5.23245289 |
| 13 | type I interferon signaling pathway (GO:0060337) | 5.23245289 |
| 14 | response to interferon-alpha (GO:0035455) | 5.20452634 |
| 15 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 5.10699102 |
| 16 | response to type I interferon (GO:0034340) | 5.09696010 |
| 17 | glycolipid catabolic process (GO:0019377) | 5.08670703 |
| 18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.01953870 |
| 19 | regulation of natural killer cell differentiation (GO:0032823) | 4.98953310 |
| 20 | striated muscle atrophy (GO:0014891) | 4.72161979 |
| 21 | neutrophil activation (GO:0042119) | 4.60246610 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 4.59534047 |
| 23 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.57124348 |
| 24 | granulocyte activation (GO:0036230) | 4.56964270 |
| 25 | ceramide catabolic process (GO:0046514) | 4.53795942 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 4.51427957 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 4.51427957 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.51427957 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.51427957 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.51427957 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 4.51427957 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.49750586 |
| 33 | natural killer cell mediated immunity (GO:0002228) | 4.41175529 |
| 34 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.41175529 |
| 35 | regulation of macrophage chemotaxis (GO:0010758) | 4.37594641 |
| 36 | positive regulation of interleukin-17 production (GO:0032740) | 4.37509014 |
| 37 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.33234892 |
| 38 | regulation of activation of Janus kinase activity (GO:0010533) | 4.32215466 |
| 39 | regulation of chemokine biosynthetic process (GO:0045073) | 4.30619159 |
| 40 | amino sugar catabolic process (GO:0046348) | 4.29613684 |
| 41 | regulation of interferon-alpha production (GO:0032647) | 4.25438432 |
| 42 | natural killer cell differentiation (GO:0001779) | 4.24328519 |
| 43 | response to peptidoglycan (GO:0032494) | 4.21306558 |
| 44 | positive regulation of T cell cytokine production (GO:0002726) | 4.17521309 |
| 45 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.15820645 |
| 46 | skeletal muscle adaptation (GO:0043501) | 4.10726538 |
| 47 | positive regulation of mast cell activation (GO:0033005) | 4.10295279 |
| 48 | muscle atrophy (GO:0014889) | 4.04186680 |
| 49 | response to thyroid hormone (GO:0097066) | 4.04126142 |
| 50 | negative regulation of viral genome replication (GO:0045071) | 3.97984715 |
| 51 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.95292090 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.94878899 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 3.89973582 |
| 54 | regulation of cholesterol storage (GO:0010885) | 3.88086044 |
| 55 | positive regulation of leukocyte degranulation (GO:0043302) | 3.85442990 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.84856000 |
| 57 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.84731926 |
| 58 | regulation of natural killer cell activation (GO:0032814) | 3.83103177 |
| 59 | regulation of defense response to virus by host (GO:0050691) | 3.82259613 |
| 60 | membrane lipid catabolic process (GO:0046466) | 3.78331176 |
| 61 | N-acetylneuraminate metabolic process (GO:0006054) | 3.78095591 |
| 62 | neutrophil mediated immunity (GO:0002446) | 3.76556756 |
| 63 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.72589892 |
| 64 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.72077376 |
| 65 | positive regulation of mast cell degranulation (GO:0043306) | 3.71153184 |
| 66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.71153184 |
| 67 | defense response to virus (GO:0051607) | 3.70347635 |
| 68 | detection of molecule of bacterial origin (GO:0032490) | 3.69309780 |
| 69 | reactive oxygen species biosynthetic process (GO:1903409) | 3.66299775 |
| 70 | positive regulation of heat generation (GO:0031652) | 3.61325817 |
| 71 | leukocyte aggregation (GO:0070486) | 3.60370009 |
| 72 | regulation of fever generation (GO:0031620) | 3.59090542 |
| 73 | positive regulation of natural killer cell activation (GO:0032816) | 3.58352707 |
| 74 | positive regulation of response to biotic stimulus (GO:0002833) | 3.58201648 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57602415 |
| 76 | sphingolipid catabolic process (GO:0030149) | 3.53937743 |
| 77 | eosinophil chemotaxis (GO:0048245) | 3.53703393 |
| 78 | respiratory burst (GO:0045730) | 3.53455751 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.53155609 |
| 80 | regulation of hypersensitivity (GO:0002883) | 3.51911813 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 3.51424826 |
| 82 | leukocyte mediated cytotoxicity (GO:0001909) | 3.51396790 |
| 83 | response to host immune response (GO:0052572) | 3.51132993 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.51132993 |
| 85 | defense response to protozoan (GO:0042832) | 3.50967273 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 3.50918328 |
| 87 | cellular extravasation (GO:0045123) | 3.50582098 |
| 88 | positive regulation of T cell migration (GO:2000406) | 3.47958986 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.46262058 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 3.45383157 |
| 91 | positive regulation of interferon-beta production (GO:0032728) | 3.41970776 |
| 92 | response to vitamin D (GO:0033280) | 3.41515605 |
| 93 | lymphocyte chemotaxis (GO:0048247) | 3.38497290 |
| 94 | monocyte chemotaxis (GO:0002548) | 3.38172664 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37337093 |
| 96 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.36914807 |
| 97 | T-helper 1 type immune response (GO:0042088) | 3.35590068 |
| 98 | positive regulation of acute inflammatory response (GO:0002675) | 3.32045610 |
| 99 | response to manganese ion (GO:0010042) | 3.31580605 |
| 100 | regulation of immunoglobulin secretion (GO:0051023) | 3.31063769 |
| 101 | superoxide anion generation (GO:0042554) | 3.30150919 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.30054324 |
| 103 | positive regulation of interleukin-12 production (GO:0032735) | 3.28899755 |
| 104 | cellular response to lipopolysaccharide (GO:0071222) | 3.28681171 |
| 105 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27167887 |
| 106 | natural killer cell activation (GO:0030101) | 3.27026605 |
| 107 | regulation of mast cell activation (GO:0033003) | 3.26808624 |
| 108 | cellular response to vitamin D (GO:0071305) | 3.25918319 |
| 109 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.24508346 |
| 110 | barbed-end actin filament capping (GO:0051016) | 3.23158594 |
| 111 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.23093091 |
| 112 | regulation of leukocyte degranulation (GO:0043300) | 3.22322361 |
| 113 | apoptotic cell clearance (GO:0043277) | 3.22196271 |
| 114 | detection of other organism (GO:0098543) | 3.20409314 |
| 115 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.20174973 |
| 116 | positive regulation of antigen processing and presentation (GO:0002579) | 3.18180984 |
| 117 | T cell migration (GO:0072678) | 3.16480805 |
| 118 | eosinophil migration (GO:0072677) | 3.14136544 |
| 119 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.13258601 |
| 120 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.13258601 |
| 121 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.13258601 |
| 122 | detection of external biotic stimulus (GO:0098581) | 3.13033881 |
| 123 | response to host defenses (GO:0052200) | 3.13011166 |
| 124 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.13011166 |
| 125 | response to host (GO:0075136) | 3.13011166 |
| 126 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.12108837 |
| 127 | cellular response to molecule of bacterial origin (GO:0071219) | 3.11328163 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 3.11094430 |
| 129 | B cell mediated immunity (GO:0019724) | 3.10978484 |
| 130 | regulation of interleukin-17 production (GO:0032660) | 3.10913413 |
| 131 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.10642897 |
| 132 | cellular response to zinc ion (GO:0071294) | 3.10109181 |
| 133 | cellular response to interferon-gamma (GO:0071346) | 3.09776607 |
| 134 | regulation of monocyte chemotaxis (GO:0090025) | 3.06530467 |
| 135 | positive regulation of cholesterol efflux (GO:0010875) | 2.98503678 |
| 136 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.98470098 |
| 137 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98296180 |
| 138 | macrophage differentiation (GO:0030225) | 2.97418300 |
| 139 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94334903 |
| 140 | regulation of T cell tolerance induction (GO:0002664) | 2.94067583 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93073732 |
| 142 | phagosome maturation (GO:0090382) | 2.91550484 |
| 143 | regulation of antigen processing and presentation (GO:0002577) | 2.90761471 |
| 144 | regulation of podosome assembly (GO:0071801) | 2.90697999 |
| 145 | adhesion of symbiont to host cell (GO:0044650) | 2.89930335 |
| 146 | virion attachment to host cell (GO:0019062) | 2.89930335 |
| 147 | macrophage activation (GO:0042116) | 2.89246356 |
| 148 | negative regulation of interleukin-17 production (GO:0032700) | 2.88444635 |
| 149 | myeloid dendritic cell activation (GO:0001773) | 2.87191532 |
| 150 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.86826067 |
| 151 | negative regulation of cell killing (GO:0031342) | 2.85631268 |
| 152 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.85631268 |
| 153 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.81886952 |
| 154 | peptide catabolic process (GO:0043171) | 2.81596760 |
| 155 | protein localization to endosome (GO:0036010) | 2.81002091 |
| 156 | pinocytosis (GO:0006907) | 2.80439677 |
| 157 | keratan sulfate catabolic process (GO:0042340) | 2.80011245 |
| 158 | low-density lipoprotein particle remodeling (GO:0034374) | 2.79336444 |
| 159 | NIK/NF-kappaB signaling (GO:0038061) | 2.76469016 |
| 160 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75796835 |
| 161 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.73586558 |
| 162 | detection of bacterium (GO:0016045) | 2.73265320 |
| 163 | detection of biotic stimulus (GO:0009595) | 2.73185662 |
| 164 | cellular response to ethanol (GO:0071361) | 2.70967511 |
| 165 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.70590282 |
| 166 | intracellular pH reduction (GO:0051452) | 2.67916699 |
| 167 | positive regulation of macrophage cytokine production (GO:0060907) | 2.67901871 |
| 168 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.67736071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.05081334 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.27098227 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.23668275 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.75105593 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 5.13051385 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.53547964 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.12202101 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.49516081 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18384080 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.08756085 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04747476 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.98059712 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.71274518 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.57869261 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.57334369 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.40796638 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.40792737 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.36594246 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30117614 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99038233 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97242641 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87582731 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84553417 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.78494231 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77843423 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71746227 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69870690 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62382090 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58313943 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.58110932 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.57811838 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52870114 |
| 33 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.44514499 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37234313 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36345470 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35896006 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34314322 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34012457 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32241756 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29959747 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27856087 |
| 42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26857312 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26375632 |
| 44 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25400390 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25234499 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24735405 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21744729 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21019669 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19061224 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13633819 |
| 51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13531031 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12133774 |
| 53 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10895887 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09520512 |
| 55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09280751 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07622991 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05733077 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.05540187 |
| 59 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05028581 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03725026 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03282931 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03282931 |
| 63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02496784 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02378715 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02296625 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00224444 |
| 67 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96284609 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96150591 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93756613 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92654503 |
| 71 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92603586 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92374869 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92324395 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89854557 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88851596 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87895789 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87790604 |
| 78 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.85536787 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83018111 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82926634 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.81640434 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80934891 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80887239 |
| 84 | MYB_26560356_Chip-Seq_TH1_Human | 0.78494353 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 0.77794158 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.77365825 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76990208 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.76740972 |
| 89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76740876 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75823999 |
| 91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75281318 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75126146 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75090885 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.73934698 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.73241680 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.73121803 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71510557 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.70933218 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.70425168 |
| 100 | MAF_26560356_Chip-Seq_TH1_Human | 0.69136187 |
| 101 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.69068447 |
| 102 | CJUN_26792858_Chip-Seq_BT549_Human | 0.67834601 |
| 103 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.67476080 |
| 104 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.66265225 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65941254 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.64389766 |
| 107 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.64161110 |
| 108 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.63532634 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62881468 |
| 110 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.62417015 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61620052 |
| 112 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.60982569 |
| 113 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.60229621 |
| 114 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.59733658 |
| 115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.58018673 |
| 116 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.56837357 |
| 117 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55894883 |
| 118 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.55501383 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54955319 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.54429657 |
| 121 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.53571569 |
| 122 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.53089088 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.52728214 |
| 124 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.52350759 |
| 125 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.51919872 |
| 126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.51641341 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.51253728 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.51031245 |
| 129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.50295143 |
| 130 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.49130086 |
| 131 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.48125585 |
| 132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.47712155 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47646350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.95231687 |
| 2 | MP0009785_altered_susceptibility_to | 4.86797905 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.96074706 |
| 4 | MP0006082_CNS_inflammation | 3.56173995 |
| 5 | MP0003303_peritoneal_inflammation | 3.37581782 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.22219114 |
| 7 | MP0005387_immune_system_phenotype | 3.12984485 |
| 8 | MP0001790_abnormal_immune_system | 3.12984485 |
| 9 | MP0005025_abnormal_response_to | 3.08016755 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.02767926 |
| 11 | MP0002419_abnormal_innate_immunity | 2.88875830 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.76123176 |
| 13 | MP0003075_altered_response_to | 2.67177833 |
| 14 | MP0003436_decreased_susceptibility_to | 2.65943941 |
| 15 | MP0000685_abnormal_immune_system | 2.53814114 |
| 16 | MP0002723_abnormal_immune_serum | 2.39240055 |
| 17 | MP0001800_abnormal_humoral_immune | 2.39055101 |
| 18 | MP0004782_abnormal_surfactant_physiolog | 2.32944139 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.30260503 |
| 20 | MP0008004_abnormal_stomach_pH | 2.23660895 |
| 21 | MP0009764_decreased_sensitivity_to | 2.23585568 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.20326316 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.14596439 |
| 24 | MP0005671_abnormal_response_to | 2.08602896 |
| 25 | MP0005166_decreased_susceptibility_to | 2.06786566 |
| 26 | MP0009278_abnormal_bone_marrow | 2.06651644 |
| 27 | MP0004858_abnormal_nervous_system | 2.05802586 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.99643740 |
| 29 | MP0001819_abnormal_immune_cell | 1.97268937 |
| 30 | MP0002163_abnormal_gland_morphology | 1.96678273 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.87471814 |
| 32 | MP0004947_skin_inflammation | 1.85594412 |
| 33 | MP0000604_amyloidosis | 1.84496967 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.83899959 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.78336547 |
| 36 | MP0003448_altered_tumor_morphology | 1.77740731 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.76360960 |
| 38 | MP0005451_abnormal_body_composition | 1.68304210 |
| 39 | MP0005164_abnormal_response_to | 1.67548855 |
| 40 | MP0004510_myositis | 1.66879411 |
| 41 | MP0008469_abnormal_protein_level | 1.66141731 |
| 42 | MP0003329_amyloid_beta_deposits | 1.62130330 |
| 43 | MP0001346_abnormal_lacrimal_gland | 1.59464175 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.50909789 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.50813038 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.47483580 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.47483580 |
| 48 | MP0003690_abnormal_glial_cell | 1.43725631 |
| 49 | MP0002254_reproductive_system_inflammat | 1.43466225 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.41708842 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.39464404 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.36186094 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.36183531 |
| 54 | MP0000343_altered_response_to | 1.35184665 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.34580193 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.34351194 |
| 57 | MP0000858_altered_metastatic_potential | 1.31509453 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.23704050 |
| 59 | MP0005365_abnormal_bile_salt | 1.23482586 |
| 60 | MP0005310_abnormal_salivary_gland | 1.23147880 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.21539588 |
| 62 | MP0003045_fibrosis | 1.21202397 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.20091686 |
| 64 | MP0000716_abnormal_immune_system | 1.17342480 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.14447788 |
| 66 | MP0001853_heart_inflammation | 1.13809113 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.10850096 |
| 68 | MP0002006_tumorigenesis | 1.10728691 |
| 69 | MP0009763_increased_sensitivity_to | 1.09299734 |
| 70 | MP0002405_respiratory_system_inflammati | 1.08666091 |
| 71 | MP0000920_abnormal_myelination | 1.06429882 |
| 72 | MP0006054_spinal_hemorrhage | 1.05299604 |
| 73 | MP0009840_abnormal_foam_cell | 1.02131310 |
| 74 | MP0001881_abnormal_mammary_gland | 1.01475470 |
| 75 | MP0008260_abnormal_autophagy | 0.98434026 |
| 76 | MP0000569_abnormal_digit_pigmentation | 0.97442185 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.96521592 |
| 78 | MP0000371_diluted_coat_color | 0.94911443 |
| 79 | MP0002398_abnormal_bone_marrow | 0.94132334 |
| 80 | MP0005257_abnormal_intraocular_pressure | 0.94125962 |
| 81 | MP0008775_abnormal_heart_ventricle | 0.91492851 |
| 82 | MP0005390_skeleton_phenotype | 0.86793353 |
| 83 | MP0003279_aneurysm | 0.86052930 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 0.84933228 |
| 85 | MP0003186_abnormal_redox_activity | 0.84137535 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.83824145 |
| 87 | MP0005647_abnormal_sex_gland | 0.81811518 |
| 88 | MP0002429_abnormal_blood_cell | 0.81197829 |
| 89 | MP0003795_abnormal_bone_structure | 0.81194389 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.80025482 |
| 91 | MP0005535_abnormal_body_temperature | 0.78423333 |
| 92 | MP0000383_abnormal_hair_follicle | 0.77204734 |
| 93 | MP0003634_abnormal_glial_cell | 0.76940112 |
| 94 | MP0005165_increased_susceptibility_to | 0.75613733 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.72627430 |
| 96 | MP0003632_abnormal_nervous_system | 0.72359224 |
| 97 | MP0010678_abnormal_skin_adnexa | 0.70456994 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.70294601 |
| 99 | MP0003091_abnormal_cell_migration | 0.68335593 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.67565500 |
| 101 | MP0001764_abnormal_homeostasis | 0.66591776 |
| 102 | MP0003195_calcinosis | 0.66509251 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.65259760 |
| 104 | MP0002736_abnormal_nociception_after | 0.64579520 |
| 105 | MP0000689_abnormal_spleen_morphology | 0.64546763 |
| 106 | MP0010307_abnormal_tumor_latency | 0.63819937 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.63390800 |
| 108 | MP0001663_abnormal_digestive_system | 0.63103077 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.62895292 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.62784055 |
| 111 | MP0003633_abnormal_nervous_system | 0.62760875 |
| 112 | MP0002722_abnormal_immune_system | 0.62714824 |
| 113 | MP0008874_decreased_physiological_sensi | 0.62230221 |
| 114 | MP0000609_abnormal_liver_physiology | 0.61931900 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.61862588 |
| 116 | MP0009115_abnormal_fat_cell | 0.61796497 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.61681739 |
| 118 | MP0001851_eye_inflammation | 0.60794904 |
| 119 | MP0001542_abnormal_bone_strength | 0.60732350 |
| 120 | MP0002928_abnormal_bile_duct | 0.58917098 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.56733990 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.56581295 |
| 123 | MP0005332_abnormal_amino_acid | 0.56460121 |
| 124 | MP0003828_pulmonary_edema | 0.54903917 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52842374 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.50043479 |
| 127 | MP0000249_abnormal_blood_vessel | 0.49584771 |
| 128 | MP0002090_abnormal_vision | 0.49027485 |
| 129 | MP0004883_abnormal_blood_vessel | 0.47710027 |
| 130 | MP0000627_abnormal_mammary_gland | 0.46903135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 8.86219709 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.86219709 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.86219709 |
| 4 | Eczematoid dermatitis (HP:0000976) | 7.74911065 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 7.38518206 |
| 6 | Recurrent abscess formation (HP:0002722) | 7.26868393 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.14974535 |
| 8 | Increased IgM level (HP:0003496) | 7.09075903 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 6.52395167 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 6.03385818 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 6.02878157 |
| 12 | Dysostosis multiplex (HP:0000943) | 5.08550412 |
| 13 | Pustule (HP:0200039) | 5.06805644 |
| 14 | Gingivitis (HP:0000230) | 4.96743514 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.94152399 |
| 16 | Loss of speech (HP:0002371) | 4.64911397 |
| 17 | Stomatitis (HP:0010280) | 4.61509986 |
| 18 | Periodontitis (HP:0000704) | 4.54208070 |
| 19 | Mutism (HP:0002300) | 4.05218354 |
| 20 | Thick nail (HP:0001805) | 4.03760366 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.97364104 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.97364104 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.97364104 |
| 24 | Recurrent skin infections (HP:0001581) | 3.89479978 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.84812132 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.84812132 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.84058397 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.76234228 |
| 29 | Obstructive lung disease (HP:0006536) | 3.76234228 |
| 30 | Poor head control (HP:0002421) | 3.60154289 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 3.57177489 |
| 32 | Cellulitis (HP:0100658) | 3.46924573 |
| 33 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.33057084 |
| 34 | Myocardial infarction (HP:0001658) | 3.24323223 |
| 35 | Vasculitis (HP:0002633) | 3.24095143 |
| 36 | Urticaria (HP:0001025) | 3.22101202 |
| 37 | Recurrent fungal infections (HP:0002841) | 3.21108117 |
| 38 | Recurrent viral infections (HP:0004429) | 3.20526557 |
| 39 | Glomerulonephritis (HP:0000099) | 3.10622440 |
| 40 | Osteolytic defects of the hand bones (HP:0009699) | 3.10273769 |
| 41 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.10273769 |
| 42 | Basal ganglia calcification (HP:0002135) | 3.08050115 |
| 43 | Tetraparesis (HP:0002273) | 3.07659728 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.05613786 |
| 45 | Hematochezia (HP:0002573) | 2.98110859 |
| 46 | Thin bony cortex (HP:0002753) | 2.96445366 |
| 47 | Axonal loss (HP:0003447) | 2.94344528 |
| 48 | Spastic tetraparesis (HP:0001285) | 2.92825418 |
| 49 | Premature loss of primary teeth (HP:0006323) | 2.88880953 |
| 50 | Diminished motivation (HP:0000745) | 2.86337060 |
| 51 | Apathy (HP:0000741) | 2.85982453 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.85062575 |
| 53 | Parakeratosis (HP:0001036) | 2.84751611 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.84187259 |
| 55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.83380468 |
| 56 | Nuclear cataract (HP:0100018) | 2.77014040 |
| 57 | Enlarged epiphyses (HP:0010580) | 2.74345372 |
| 58 | Retinal atrophy (HP:0001105) | 2.73203329 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.71764710 |
| 60 | Neuronal loss in central nervous system (HP:0002529) | 2.71741290 |
| 61 | Agnosia (HP:0010524) | 2.71408211 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.69924535 |
| 63 | Upper motor neuron abnormality (HP:0002127) | 2.67136656 |
| 64 | Disinhibition (HP:0000734) | 2.63586190 |
| 65 | Orchitis (HP:0100796) | 2.63413392 |
| 66 | Joint swelling (HP:0001386) | 2.63262421 |
| 67 | Gingival bleeding (HP:0000225) | 2.60437151 |
| 68 | Purpura (HP:0000979) | 2.60180800 |
| 69 | Inappropriate behavior (HP:0000719) | 2.55539893 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.55133262 |
| 71 | Optic neuritis (HP:0100653) | 2.55133262 |
| 72 | Metaphyseal irregularity (HP:0003025) | 2.54510198 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.53509355 |
| 74 | Cheilitis (HP:0100825) | 2.52756896 |
| 75 | Spontaneous hematomas (HP:0007420) | 2.52366892 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.51832767 |
| 77 | Complement deficiency (HP:0004431) | 2.49124531 |
| 78 | Abnormality of the periventricular white matter (HP:0002518) | 2.46111475 |
| 79 | Subacute progressive viral hepatitis (HP:0006572) | 2.46018799 |
| 80 | IgA deficiency (HP:0002720) | 2.43590703 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.43208743 |
| 82 | Myositis (HP:0100614) | 2.42508835 |
| 83 | Abnormality of T cell number (HP:0011839) | 2.41329214 |
| 84 | Osteomyelitis (HP:0002754) | 2.39403865 |
| 85 | Global brain atrophy (HP:0002283) | 2.38959298 |
| 86 | Progressive neurologic deterioration (HP:0002344) | 2.35455902 |
| 87 | Increased serum ferritin (HP:0003281) | 2.34317119 |
| 88 | Delayed epiphyseal ossification (HP:0002663) | 2.31468157 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.29547385 |
| 90 | Bone pain (HP:0002653) | 2.29027397 |
| 91 | Eosinophilia (HP:0001880) | 2.28947430 |
| 92 | Esophageal neoplasm (HP:0100751) | 2.27305457 |
| 93 | Neoplasm of head and neck (HP:0012288) | 2.27305457 |
| 94 | Pulmonary infiltrates (HP:0002113) | 2.25651694 |
| 95 | Neutropenia (HP:0001875) | 2.23812905 |
| 96 | Abnormality of the costochondral junction (HP:0000919) | 2.21790517 |
| 97 | Hemoptysis (HP:0002105) | 2.21088843 |
| 98 | Leukocytosis (HP:0001974) | 2.20690909 |
| 99 | Chronic sinusitis (HP:0011109) | 2.19712072 |
| 100 | Dementia (HP:0000726) | 2.19495179 |
| 101 | Recurrent lower respiratory tract infections (HP:0002783) | 2.18436846 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 2.17392104 |
| 103 | Neurofibrillary tangles (HP:0002185) | 2.16803388 |
| 104 | Micronodular cirrhosis (HP:0001413) | 2.15425558 |
| 105 | Cerebral hemorrhage (HP:0001342) | 2.15000889 |
| 106 | Hypochromic anemia (HP:0001931) | 2.14914313 |
| 107 | Cardiomegaly (HP:0001640) | 2.14146778 |
| 108 | Widely patent fontanelles and sutures (HP:0004492) | 2.14114047 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 2.13086988 |
| 110 | Peripheral demyelination (HP:0011096) | 2.12713235 |
| 111 | Amyloidosis (HP:0011034) | 2.12593378 |
| 112 | Porencephaly (HP:0002132) | 2.10861025 |
| 113 | Personality changes (HP:0000751) | 2.10749666 |
| 114 | Xanthomatosis (HP:0000991) | 2.06890008 |
| 115 | Abnormality of T cell physiology (HP:0011840) | 2.05893613 |
| 116 | Polyneuropathy (HP:0001271) | 2.05811803 |
| 117 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05156097 |
| 118 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05156097 |
| 119 | Absent frontal sinuses (HP:0002688) | 2.03175125 |
| 120 | Sepsis (HP:0100806) | 2.02604333 |
| 121 | Progressive visual loss (HP:0000529) | 2.01979452 |
| 122 | Skin ulcer (HP:0200042) | 2.00074198 |
| 123 | Thoracic kyphosis (HP:0002942) | 1.97797460 |
| 124 | Pathologic fracture (HP:0002756) | 1.97706883 |
| 125 | Abnormality of complement system (HP:0005339) | 1.97244672 |
| 126 | Conjunctival telangiectasia (HP:0000524) | 1.97160815 |
| 127 | Cleft eyelid (HP:0000625) | 1.97102444 |
| 128 | Increased CSF protein (HP:0002922) | 1.95417251 |
| 129 | Prolonged neonatal jaundice (HP:0006579) | 1.94439944 |
| 130 | Meningitis (HP:0001287) | 1.91356106 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.89701313 |
| 132 | T lymphocytopenia (HP:0005403) | 1.87896739 |
| 133 | Protuberant abdomen (HP:0001538) | 1.87099150 |
| 134 | Lower limb hyperreflexia (HP:0002395) | 1.86937537 |
| 135 | Mitral stenosis (HP:0001718) | 1.86657652 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86563560 |
| 137 | Malnutrition (HP:0004395) | 1.86291822 |
| 138 | Granulocytopenia (HP:0001913) | 1.85747331 |
| 139 | Palmoplantar hyperkeratosis (HP:0000972) | 1.85086934 |
| 140 | Abnormality of the common coagulation pathway (HP:0010990) | 1.84624273 |
| 141 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83459923 |
| 142 | Fair hair (HP:0002286) | 1.82025359 |
| 143 | Multiple enchondromatosis (HP:0005701) | 1.81937416 |
| 144 | Prostate neoplasm (HP:0100787) | 1.80777683 |
| 145 | Peritonitis (HP:0002586) | 1.80515519 |
| 146 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.80247235 |
| 147 | Abnormality of T cells (HP:0002843) | 1.78990935 |
| 148 | Memory impairment (HP:0002354) | 1.78189665 |
| 149 | Petechiae (HP:0000967) | 1.78065133 |
| 150 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77651559 |
| 151 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77312500 |
| 152 | Increased IgE level (HP:0003212) | 1.77241496 |
| 153 | Joint hemorrhage (HP:0005261) | 1.76709977 |
| 154 | Homocystinuria (HP:0002156) | 1.75441366 |
| 155 | Abnormality of homocysteine metabolism (HP:0010919) | 1.75441366 |
| 156 | Polycythemia (HP:0001901) | 1.74830461 |
| 157 | Hypophosphatemia (HP:0002148) | 1.74560208 |
| 158 | Esophageal varix (HP:0002040) | 1.73727109 |
| 159 | Stroke (HP:0001297) | 1.73417436 |
| 160 | Supranuclear gaze palsy (HP:0000605) | 1.73387088 |
| 161 | Hypokinesia (HP:0002375) | 1.72711445 |
| 162 | Arthralgia (HP:0002829) | 1.72216412 |
| 163 | Acrocyanosis (HP:0001063) | 1.68542513 |
| 164 | Abnormality of the prostate (HP:0008775) | 1.68033203 |
| 165 | Mucosal telangiectasiae (HP:0100579) | 1.67015282 |
| 166 | Keratoconjunctivitis sicca (HP:0001097) | 1.66730196 |
| 167 | Restrictive lung disease (HP:0002091) | 1.63482111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 7.67682422 |
| 2 | MAP3K14 | 5.15650083 |
| 3 | RIPK4 | 4.90680055 |
| 4 | TYK2 | 3.50253483 |
| 5 | TGFBR2 | 3.03414252 |
| 6 | IRAK3 | 2.91186088 |
| 7 | JAK3 | 2.80598885 |
| 8 | JAK1 | 2.73715910 |
| 9 | ACVR1B | 2.71489673 |
| 10 | DDR2 | 2.61906570 |
| 11 | BLK | 2.55557328 |
| 12 | TBK1 | 2.48110626 |
| 13 | IKBKE | 2.29777592 |
| 14 | FGFR4 | 2.19034203 |
| 15 | IRAK4 | 2.16898288 |
| 16 | CSK | 2.04548859 |
| 17 | CAMKK2 | 1.99095437 |
| 18 | IKBKB | 1.91818136 |
| 19 | BCR | 1.71015128 |
| 20 | CAMK1D | 1.68335392 |
| 21 | EPHA3 | 1.67306026 |
| 22 | FGR | 1.66864523 |
| 23 | CSF1R | 1.64133281 |
| 24 | DAPK2 | 1.61090339 |
| 25 | CDC42BPA | 1.55751443 |
| 26 | TAOK2 | 1.49140575 |
| 27 | EPHB1 | 1.47382595 |
| 28 | STK4 | 1.43998182 |
| 29 | FRK | 1.40496924 |
| 30 | TXK | 1.32773126 |
| 31 | EIF2AK2 | 1.32174076 |
| 32 | MAP3K3 | 1.30843641 |
| 33 | EIF2AK1 | 1.30687416 |
| 34 | FGFR3 | 1.29368433 |
| 35 | PDK2 | 1.27442978 |
| 36 | ERBB3 | 1.26407564 |
| 37 | MATK | 1.22166998 |
| 38 | MAP2K3 | 1.18081390 |
| 39 | SYK | 1.17798956 |
| 40 | MAP3K13 | 1.16010458 |
| 41 | MST4 | 1.13025739 |
| 42 | CHUK | 1.12129240 |
| 43 | RPS6KA4 | 1.11100837 |
| 44 | YES1 | 1.10991794 |
| 45 | MOS | 1.05135436 |
| 46 | TAOK1 | 1.04818667 |
| 47 | MAP4K1 | 1.04065760 |
| 48 | HCK | 1.02601438 |
| 49 | BMPR2 | 1.02355184 |
| 50 | RIPK1 | 1.01045013 |
| 51 | JAK2 | 1.00595062 |
| 52 | LYN | 0.98574279 |
| 53 | CDK6 | 0.94888225 |
| 54 | TESK2 | 0.93907711 |
| 55 | PRPF4B | 0.92977503 |
| 56 | PLK2 | 0.89085507 |
| 57 | CAMK1G | 0.88843759 |
| 58 | LCK | 0.85789345 |
| 59 | CCNB1 | 0.85491964 |
| 60 | ADRBK2 | 0.82983686 |
| 61 | ZAP70 | 0.81834510 |
| 62 | TGFBR1 | 0.80554704 |
| 63 | KIT | 0.78304215 |
| 64 | MARK3 | 0.77020204 |
| 65 | TAOK3 | 0.76864151 |
| 66 | PRKCD | 0.75511751 |
| 67 | TEC | 0.75146015 |
| 68 | ERN1 | 0.72519364 |
| 69 | RPS6KA2 | 0.68124039 |
| 70 | PRKCQ | 0.66539850 |
| 71 | TESK1 | 0.65381019 |
| 72 | BTK | 0.65233129 |
| 73 | FYN | 0.64699191 |
| 74 | IRAK2 | 0.62150095 |
| 75 | PIK3CA | 0.62100253 |
| 76 | RPS6KC1 | 0.60714481 |
| 77 | RPS6KL1 | 0.60714481 |
| 78 | MAPK11 | 0.59544582 |
| 79 | CAMKK1 | 0.59438766 |
| 80 | TTN | 0.59075039 |
| 81 | LIMK1 | 0.58875619 |
| 82 | PAK4 | 0.58514813 |
| 83 | TYRO3 | 0.57931806 |
| 84 | PDGFRA | 0.56668077 |
| 85 | CSNK1A1L | 0.55553757 |
| 86 | GRK7 | 0.54680812 |
| 87 | RPS6KA5 | 0.54678611 |
| 88 | NME2 | 0.53074420 |
| 89 | NEK6 | 0.52077124 |
| 90 | TRPM7 | 0.51497187 |
| 91 | PDPK1 | 0.50935586 |
| 92 | PRKCE | 0.50816272 |
| 93 | RPS6KA6 | 0.48266575 |
| 94 | ARAF | 0.47915068 |
| 95 | ALK | 0.47444328 |
| 96 | MAP2K6 | 0.47388131 |
| 97 | PIM2 | 0.45593351 |
| 98 | MAP3K11 | 0.44763293 |
| 99 | MST1R | 0.44138440 |
| 100 | ERBB4 | 0.40912251 |
| 101 | EPHB2 | 0.40808585 |
| 102 | ABL1 | 0.40647901 |
| 103 | PRKG2 | 0.39041694 |
| 104 | ABL2 | 0.38530116 |
| 105 | ADRBK1 | 0.38230987 |
| 106 | MAP3K5 | 0.36927221 |
| 107 | MAP3K10 | 0.36739441 |
| 108 | CDK4 | 0.36489318 |
| 109 | KSR1 | 0.35225447 |
| 110 | MAPK7 | 0.35180537 |
| 111 | STK24 | 0.34930874 |
| 112 | NLK | 0.34846921 |
| 113 | MAPK4 | 0.34404658 |
| 114 | PDGFRB | 0.33665579 |
| 115 | EGFR | 0.33366613 |
| 116 | SIK3 | 0.32694291 |
| 117 | IRAK1 | 0.31378864 |
| 118 | IGF1R | 0.31352426 |
| 119 | MAP3K2 | 0.30983271 |
| 120 | MAPK12 | 0.30882282 |
| 121 | KSR2 | 0.30747565 |
| 122 | NTRK1 | 0.30489752 |
| 123 | PIM1 | 0.29044090 |
| 124 | SRC | 0.28539391 |
| 125 | PDK1 | 0.25202593 |
| 126 | PKN1 | 0.24706261 |
| 127 | DAPK3 | 0.23824897 |
| 128 | MAP3K8 | 0.23702176 |
| 129 | STK10 | 0.22586599 |
| 130 | MAP3K12 | 0.22400084 |
| 131 | NEK9 | 0.20976936 |
| 132 | DAPK1 | 0.20006578 |
| 133 | CDK9 | 0.19184708 |
| 134 | MINK1 | 0.18602034 |
| 135 | PRKACG | 0.17771848 |
| 136 | MAP3K1 | 0.17262767 |
| 137 | BMPR1B | 0.15517880 |
| 138 | INSR | 0.14286069 |
| 139 | FES | 0.13731605 |
| 140 | PRKCA | 0.12931110 |
| 141 | ITK | 0.11911916 |
| 142 | MAPKAPK2 | 0.11391997 |
| 143 | PRKCZ | 0.10775448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.34760003 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.33255685 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.67972873 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.45654419 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.24069912 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.20610259 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.12219426 |
| 8 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.07993125 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.98403073 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.93839203 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.70122579 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67108259 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.66374821 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.44710549 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 2.44391915 |
| 16 | Measles_Homo sapiens_hsa05162 | 2.43289938 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.36732314 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 2.35395417 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.34291732 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 2.34116797 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.31437017 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.17767403 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00790612 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.97713472 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89402435 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82944047 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54293976 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52517147 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.50850302 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.41050040 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40770676 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40147881 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35233621 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.33511090 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.33173718 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28130513 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25123030 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 1.23459596 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.15515893 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15365309 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09945479 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08135521 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08088323 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07486148 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.06262070 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.04986931 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04971049 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99676849 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93387500 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.93360802 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89678648 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87858802 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80302087 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80084560 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79556328 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.76111315 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73372380 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67703838 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.66306529 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61626428 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58018452 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56099065 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55499348 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55132563 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.51488760 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50502360 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49069380 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47052967 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38837451 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37388003 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34292634 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34232308 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34076886 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.32930995 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31946933 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31738422 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.31191203 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30730070 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30592912 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29704498 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29628600 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28290536 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.27689012 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27351684 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.27214445 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26720059 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25601543 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25393323 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24280881 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23831500 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22859642 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22532662 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21949809 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21657736 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.21121772 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20652125 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20128834 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18096206 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.17632343 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17237910 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17173709 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16773006 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15417330 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.15272040 |
| 105 | Proteasome_Homo sapiens_hsa03050 | 0.14627031 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14283458 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.12785431 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.12128173 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.10462380 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.09332023 |
| 111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.08770284 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08437228 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.07933269 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07531229 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.06885377 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.04280603 |
| 117 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.03973315 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03472421 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.02443714 |
| 120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.02232990 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01551865 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | -0.0259825 |
| 123 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0187140 |
| 124 | PPAR signaling pathway_Homo sapiens_hsa03320 | -0.0172365 |

